MedPath

Disposable 7.5Fr Electronic Flexible Ureteroscope Combined 10Fr Ureteral Access Sheath for Treatment of Renal Stone <2cm

Not Applicable
Completed
Conditions
Ureteroscopy
Urolithiasis
Interventions
Device: Using disposable 7.5Fr electronic flexible ureteroscope combined 10Fr ureteral access sheath to treat renal stone <2cm
Registration Number
NCT06491524
Lead Sponsor
Ningbo No. 1 Hospital
Brief Summary

Observation efficacy and safety of disposable f7.5 electronic flexible ureteroscope combined f10 ureteral guide sheath for treatment of renal stone \<2cm.

Detailed Description

Using disposable 7.5Fr electronic flexible ureteroscope combined 10Fr ureteral guide sheath to treat renal stone \<2cm, and investigating its efficacy and safety.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  1. Patients with kidney stones less than 2cm who choose to perform "Flexible ureteroscopic holmium laser lithotripsy";
  2. Over 18 years old, male or female;
  3. No hydronephrosis or mild to moderate hydronephrosis (collection system separation is less than 2cm);
  4. The subject has no mental illness or language dysfunction, can understand the situation of this study and has signed an informed consent form, and is estimated to be able to cooperate with the completion of the entire study;
  5. No urinary tract infection or no clinical manifestations of urinary tract infection;
  6. Patients with urinary tract infection, negative urine culture, and no fever need to undergo antibiotic treatment for more than 3 days; urinary routine examination suggests urinary tract infection, positive urine culture, and patients without fever need to undergo antibiotic treatment for more than 7 days, till the urine culture turns negative.
Exclusion Criteria
  1. Patients with a previous history of ureteral stenosis or who have undergone open, laparoscopic ureteral, nephrectomy and lithotripsy;
  2. Fever or urinary tract infection is not treated according to the inclusion criteira;
  3. Pregnant women and women's menstrual periods;
  4. Cannot tolerate anaesthesia or surgery due to serious systemic diseases, heart disease, lung insufficiency and failure of important organs;
  5. Anatomical malformations such as polycystic kidneys, horseshoe kidneys, and ectopic kidneys;
  6. Patients with high suspicion of ureteral stenosis or diseases that are considered unsuitable to participate in this clinical study;
  7. Patients indwelling double J stent preoperatively;
  8. Patients who need bilateral upper urinary tract surgery at the same time.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
7.5Fr flexible ureteroscope combined 10Fr ureteral access sheathUsing disposable 7.5Fr electronic flexible ureteroscope combined 10Fr ureteral access sheath to treat renal stone <2cmUsing disposable 7.5Fr electronic flexible ureteroscope combined 10Fr ureteral access sheath to treat renal stone \<2cm
Primary Outcome Measures
NameTimeMethod
Success rate of Accessing1 day

success rate of UAS placement (SRUP)

Secondary Outcome Measures
NameTimeMethod
overactive bladder symptom score (OABSS)1 month

Overactive bladder symptom score (OABSS) before and after the operation

Quality of life (QOL) questionnaire1 month

Quality of life (QOL) before and after the operation

Evaluation of intraoperative ureteral injury1 day

Evaluation of intraoperative ureteral injury according to the standards proposed by Traxer et. al.

Stone free rate1 and 30 days

stone free rate (SFR)

Trial Locations

Locations (1)

Ningbo First hospital

🇨🇳

Ningbo, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath